4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-26-020704
Director sold 22,000 shares at $7.22 ($158,796)
- Director acquired 27,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MOYES JAY M Director | 2026-06-11 | Grant or award 10b5-1 | +27,000 | 80,322 | D | ||
| MOYES JAY M Director | 2026-06-12 | Sale 10b5-1 | −22,000 | $7.22 | $158,796 | 58,322 | D |
| Open-market sales · 22,000 sh · avg $7.22 · $158,796 | |||||||
Loading xslF345X06/rdgdoc.xml…